David M. Charytan, MD, MSc, receives J. Michael Lazarus Award
Click Here to Manage Email Alerts
Key takeaways:
- Nephrologist and professor of medicine David M. Charytan, MD, MSc, is the recipient of the 2024 J. Michael Lazarus Award.
- The award was presented at the NKF Spring Clinical Meetings.
The National Kidney Foundation has awarded the J. Michael Lazarus Distinguished Award to David M. Charytan, MD, MSc.
The award is presented annually in honor of J. Michael Lazarus “for his major contributions to the clinical science and care of dialysis patients and to recognize individuals whose research has yielded novel insights related to renal replacement therapy,” according to a NKF press release.
“From his clinical innovations to his continued active research, Dr. Charytan strives to better understand and identify therapies that address the needs of patients living with chronic kidney disease, particularly those on dialysis,” Sylvia E. Rosas, MD, MSCE, NKF president, said in the release.
Charytan is the director of the division of nephrology at New York University Langone Medical Center. He is also a founding steering committee member of the NIH Hemodialysis Novel Therapies Consortium.
“It’s a true honor to be recognized by the NKF and particularly meaningful that it’s an award named after Mike Lazarus, who did so much to improve the lives of kidney patients with end-stage renal disease,” Charytan said in the release. “Being acknowledged by your peers for a career’s worth of effort is incredibly gratifying and rewarding.”
Read more about
Click Here to Manage Email Alerts